Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 56,116 | 54,568 | 52,775 | 65,675 | 57,102 |
| Cost of Goods | 13,284 | 11,857 | 13,218 | 16,836 | 12,495 |
| Gross Profit | 42,832 | 42,711 | 39,557 | 48,839 | 44,607 |
| Operating Expenses | 34,531 | 38,676 | 35,410 | 39,659 | 42,709 |
| Operating Income | 8,585 | 4,892 | 4,365 | 10,016 | 2,393 |
| Interest Expense | 3,339 | 3,325 | 3,312 | 3,279 | 2,947 |
| Other Income | 763 | 746 | 495 | -12,049 | 261 |
| Pre-tax Income | 6,009 | 2,313 | 1,548 | -5,312 | -293 |
| Income Tax | 213 | 187 | 147 | 294 | 67 |
| Net Income Continuous | 5,796 | 2,126 | 1,401 | -5,606 | -360 |
| Net Income | $5,796 | $2,126 | $1,401 | $-5,606 | $-360 |
| EPS Basic Total Ops | 0.12 | 0.05 | 0.03 | -0.12 | -0.01 |
| EPS Basic Continuous Ops | 0.12 | 0.05 | 0.03 | -0.12 | -0.01 |
| EPS Diluted Total Ops | 0.12 | 0.05 | 0.03 | -0.12 | -0.01 |
| EPS Diluted Continuous Ops | 0.12 | 0.05 | 0.03 | -0.12 | -0.01 |
| EBITDA(a) | $11,461 | $7,768 | $7,243 | $12,469 | $4,862 |